Purpose
To evaluate a multivalent meningococcal conjugate vaccine in expanded age group to expand vaccine access and reduce deaths from meningococcal meningitis in low- and middle-income countries.
Grantee
Division
Global Health
Date
OCTOBER 2026
Region served
AFRICA
Committed amount
$1,615,782
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
30
Grantee location
Seoul, Korea, Republic of
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.